Saturday, 25 February 2017

Western Europe Teleradiology Market (By Modality: X-ray, Ultrasound, Computed Tomography) to Expand at a CAGR 18.5% by 2023


Teleradiology is a comprehensive part of telehealth services. Teleradiology refers to electronic transmission of radiology images between two locations via technology for emergency services or second opinion. This service bridges the gap between the imbalance of demand and supply of expert radiologists and diagnostic services. Initially, the image transfer process was tedious, time consuming, and provided unreliable image clarity and quality. Currently, teleradiology shows the rapid progression in image processing and transmission tools and technologies. Hence, radiology experts believe that the teleradiology market will provide lucrative business opportunities in the near future.
Western Europe is a developed market and accounts for about 70% to 75% share of the teleradiology market in Europe. Consistent evolution of information and communication technologies and shortage of expert radiologists across Europe are likely to drive the market during the forecast period. Furthermore, cost effective solutions, emergency coverage, and increasing number of imaging procedures are anticipated to boost the teleradiology market in Western Europe. However, complex regulations, language barrier, and high cost of technology (initial investment) are expected to restrain the teleradiology market in the region.
The teleradiology market in Western Europe has been segmented based on modality into X-ray, ultrasound, computed tomography, magnetic resonance imaging (MRI), and nuclear imaging. X-ray teleradiology was the largest segment in 2014. The segment is likely to maintain its market share during forecast period owing to increasing number of X-ray procedures and need for expert radiologist advice because of complexity of images due to advanced technology. Ultrasound teleradiology accounted for the second largest share of the market due to development of 3-D and 4-D ultrasound platforms, absence of ionizing radiation, and increasing reliability of receiving clear images. However, CT teleradiology is considered a highly lucrative segment during the forecast period from 2015 to 2023 due to its ability to visualize complex body parts such as brain, lungs, and cardiac abnormalities, and favorable reimbursement policies.
Geographically, the teleradiology market in Western Europe has been segmented into six regions: the U.K., Germany, Spain, Italy, the Netherlands, and Rest of Western Europe. The U.K. and Germany together accounted for the largest share of the market. The U.K. accounted for the largest share of the teleradiology market in Western Europe in 2014. The market in the country is likely to witness the highest growth during forecast period owing to rapid development in digital image processing technology, high implementation of picture archiving communication systems (PACS), and presence of major market players along with a number of other domestic service providers. Germany was the second largest market in 2014 due to lack of expert radiologists and government initiatives to encourage the teleradiology market. However, the market in Germany is anticipated to expand at a slow growth rate as compared to that in the U.K. due to stringent cross-border regulations and high cost associated with teleradiology.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Asia Pacific platelet rich plasma market is expected to Reach US$110.0 Million by 2023

The rising incidence of orthopedic diseases, neurological disorders, cardiovascular diseases, sports injury, and obesity has proven crucial in keeping demand for platelet rich plasma (PRP) high in Asia Pacific. The introduction of advanced devices for better efficiency in PRP preparation has also bode well for the market. These factors are expected to boost the Asia Pacific platelet rich plasma market at a CAGR of 15.4% between 2015 and 2023, as per Transparency Market Research (TMR).
TMR pegs the overall value of the market at US$30 mn in 2014, and has projected it to reach US$110.0 mn by the end of 2023. With millions opting for non-invasive cosmetic surgery every year, and the number exhibiting a robust increase, demand from the Asia Pacific platelet rich plasma market is expected to rise considerably in the forthcoming years.
Among other market drivers, the increasing awareness about PRP products and devices across emerging economies will prove extremely beneficial for the market. However, the rising commercialization of these treatments has fueled their prices. This acts as a major bottleneck restraining the market’s trajectory. Threat associated with therapy failure also limits the market to an extent.
Rising Investment in Healthcare Puts China at the Fore of Asia-Pacific PRP Market
Regionally, the Asia Pacific platelet rich plasma market comprises 11 major segments, comprising the Philippines, India, Australia, China, Thailand, Singapore, Malaysia, Hong Kong, Taiwan, South Korea, Japan, and Rest of Asia Pacific. Of these, China held the leading share of 36.1% in the Asia Pacific PRP market based on revenue, trailed by Australia. The China market for platelet rich plasma is expected to exhibit a CAGR of 17.0% between 2015 and 2023. The high awareness about the PRP technology across various treatments, the rising investment in healthcare, and research and development activities are the key factors bolstering demand from the aforementioned countries.
Currently, South Korea holds the third-largest share in the Asia Pacific PRP market. However, the market in India is expected to rise at a faster pace. Currently India holds a smaller share in the Asia Pacific PRP market compared to other developed markets in the region. However, the increasing geriatric pool in the country, presence of skilled doctors, and increasing awareness will boost demand for PRP in India.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Global Mouth Ulcers Treatment Market to Register 3.8% CAGR 2020 due to Rising Awareness about Mouth Ulcers

Global Mouth Ulcers Treatment Market: Snapshot
Mouth ulcers are non-critical and are formed due to oral injuries or wounds affecting the mucous membrane. Some of the factors resulting in the formation of mouth ulcers are stress, infection, injury, allergy, nutritional deficiencies, or genetic tendency, which further leads to intense pain. The inclination of consumers towards a healthy lifestyle is estimated to offer promising opportunities for the key players operating in the global mouth ulcer treatment market across the globe. The increasing level of competition and the emergence of innovative products are likely to encourage the growth of the global mouth ulcers market throughout the forecast period.
As per the research study, in 2013, the global market for mouth ulcer treatment was worth US$1,242.6 mn. The market is estimated to register a 3.80% CAGR between 2014 and 2020, reaching a value of US$1,596.9 mn by the end of 2020. Furthermore, technological advancements and innovations in the medicine field are expected to bolster global mouth ulcer treatment in the near future.
Rising Prevalence Rate of Mouth Ulcers to Encourage Growth in North America
From a geographical perspective, North America is anticipated to lead the global mouth ulcers market and is expected to remain in the topmost position throughout the forecast period. As per the study, this region is estimated to account for a key share of the market by the end of 2020, thanks to the growing awareness among consumers regarding the availability of effective mouth ulcer treatments. In addition, the increasing demand for mouth ulcer treatments owing to the rising prevalence rate is predicted to fuel the growth of the North America mouth ulcer treatment market in the coming few years.
Furthermore, Europe is anticipated to witness considerable growth in the coming years and remain in the second position in terms of revenue. The rising geriatric population in this region is one of the key factors anticipated to bolster mouth ulcers market in Europe. On the other hand, Asia Pacific is projected to register robust growth in the next few years, due to the favorable government initiatives and the rising number of mouth ulcer cases. The untapped opportunities in this region, especially in developing economies are predicted to supplement the growth of the market in the next few years.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Molecular Diagnostics Market (By Technology: Polymerase Chain Reaction, Hybridization, Mass Spectrometry and Others) to Expand at a CAGR 11.4% by 2023

Molecular diagnostics primarily refers to the class of diagnostic tests that identifies nucleic acids or proteins at the molecular level. Molecular diagnostics has emerged as one of the fastest growing segments in in vitro diagnostics industry. The market for molecular diagnostics has expanded rapidly since 1990’s with the introduction of PCR test for HIV and Chlamydia trachomatis and Neisseria gonorrhea (CT/NG). Since then, within a span of 20 years market has shown a significant growth. Currently, molecular diagnostics kits are being widely adopted for testing genetic diseases, cancer, hepatitis virus and hospital acquired infections. Likewise, molecular diagnostics kits are also being used extensively for blood donor screening test for hepatitis and HIV.
The molecular diagnostic tests uses a number of technologies such as polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. The polymerase chain reaction dominated the molecular diagnostics market in Europe accounting for the share of 40.1% in 2014 as the technique is cost-effective way for copying or amplification of small segments of DNA or RNA. However, next generation sequencing segment is expected to register the fastest growth during the forecast period due to its high throughput, speed, flexibility which has ability to generate hundreds of gigabases of data in a single sequencing run.
The Europe molecular diagnostics market has been segmented into five major regions, namely, Northern Europe, Eastern Europe, Western Europe, Southern Europe, and Rest of Europe, which are further categorized into various countries under each region. Western Europe dominated the Europe molecular diagnostic market in 2014 with a share of 47.1% due to factors such as rising prevalence of infectious disorders, and increasing number of government initiatives. In addition, growing preference of the population to opt for affordable molecular diagnostic tests is another factor supporting the market growth in this region. Eastern Europe is projected to be the most lucrative market for Europe molecular diagnostic market and is expected to expand at the highest growth rate from 2015 to 2023. Factors propelling the growth of the Europe molecular diagnostic market are rising disposable income among population, and rising health care awareness among the people pertaining to molecular diagnostic tests.
F. Hoffmann-La Roche Ltd. dominated the Europe molecular diagnostic market in 2014. Major factors attributed to its dominance are broad product portfolio and widespread market presence. Abbott Laboratories secured the second market position offering a wide range of molecular diagnostic tests. Other players in the Europe molecular diagnostic market include QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Siemens AG, Alere. Inc., BioMerieux, Bio-Rad Laboratories, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and others.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Friday, 24 February 2017

Mobile Applications for Melanoma Detection Market is Expected to Reach US$ 1.5 Million by 2022, in Europe and Israel

Europe and Israel Mobile Applications for Melanoma Detection Market: Snapshot
Melanoma is primarily linked to prolonged exposure to UV radiation during childhood and this preventable skin condition has been on a rise in recent years. A significant spike in the incidence rate of melanoma has driven the need for effective and swift detection tools and techniques. Early detection of melanoma is crucial for improved prognosis and this can be achieved by skin surveillance and screening. This growing need, coupled with an increase in efforts to improve the awareness levels about this skin condition, has spurred the trend of early diagnosis. This has, in turn, driven the demand for mobile applications used for the detection of melanoma in Europe as well as Israel.
Impressive Performance of Greece Market despite Economic Volatility
Regionally, the market for mobile applications for melanoma detection is split into Europe and Israel. Europe accounts for the dominant share and the opportunity in this market is slated to be worth US$1.4 mn by 2022. While the mobile application market for melanoma detection in Europe is fueled by the surge in mHealth trends and rising incidence of melanoma, it is significantly driven by the performance of the market in Greece.
Despite the economic volatility in Greece, the market for mobile applications for melanoma detection will continue to witness growth owing to the development of eHealth infrastructure in the country and rising number of melanoma cases. Growing smartphone penetration is also a key factor driving the Greece market for mobile applications for melanoma detection. In addition to this, a high doctor-patient ratio has enabled the establishment of a strong network of doctors dedicated toward the detection of melanoma through mobile health services.
Strong Penetration of Smartphones and Expanding 3G, 4G Networks Supporting Market in Israel
Israel is anticipated to witness impressive growth during the forecast period, exhibiting a 61.2% CAGR from 2014 to 2022. The rising prevalence of melanoma has been the primary driving factor in this region, especially based on information provided by the Israel Cancer Association. The organization states that in 2012 alone, nearly 1,300 new cases of malignant melanoma were reported in the country. This has resulted in increasing awareness among the general population regarding self-screening and early detection of cancer.
Rapid expansion of 3G and 4G networks and several government initiatives have also supported the development of the mobile applications market for melanoma detection in Israel. Google Inc.’s research titled ‘Our Mobile Planet’ finds that the smartphone penetration rate in the country crossed 56.0% in 2013. These factors are slated to drive the regional market to reach a value of US$77,765.3 by 2022.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Geriatric Medicines Market to Rise at a CAGR 7.3% by 2023

Geriatric medicines are a specialty branch of medical science that provides diagnosis and treatment options for the elderly. Most of the geriatrics is unable to take their medication properly at scheduled time due to complex medical and psychological problems. The geriatric population requires special care and attention for the speedy recovery of disease or disorder. The global geriatric medicines market is experiencing significant growth due to increasing government support toward old people for their health, safety, and nursing care. Developed nations already have quality geriatric care management systems in place and developing nations are making high investments in geriatric care.
There has been an unprecedented growth in the global geriatric population. According to the World Health Organization (WHO), people over the age of 65 forms the fastest-growing population segment globally. This rise in geriatric population has led to an increase in the incidence and prevalence of chronic diseases. In America, the healthcare cost consists of 95% are for chronic diseases. According to the State of Aging and Health in America 2013 it is estimated that by 2030, health care spending will increase by 25%, largely because the population will be older. However, this estimate does not take into account the higher costs of new technologies and inflation. The increasing prevalence of geriatric diseases, rise in chronic diseases, favorable government initiatives toward geriatrics, and increase in health care infrastructure is likely to boost market growth.
The global geriatric medicines market has been estimated on the basis of therapeutic category and conditions. Based on therapeutic category the market is divided into eight segments on the basis of therapeutic category: analgesic, antihypertensive, statins, antidiabetic, proton pump inhibitor, anticoagulant, antipsychotic & antidepressant and others. Among these segments, analgesics accounted for the largest market share in 2014 in terms of revenue and would continue to dominate the market during the forecast period. Owing to increase in the chronic diseases, favorable government initiatives toward geriatrics and increase in healthcare infrastructure is likely to boost market growth.
On the basis of condition the geriatric medicines market is segmented into cardiovascular, arthritis, neurological, cancer, osteoporosis, respiratory, and others. Cardiovascular holds the largest market share in 2014 in terms of revenue due to better effectively and increased efficiency. The segment is also expected to register the fastest growth during the forecast period. Factors such as rising geriatrics, obesity leading to the rise in risk of heart attacks and strokes support the growth of this segment.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Defibrillators Market (Advanced Life Support Defibrillators and Automated External Defibrillators) to Rise at a CAGR 7.6%. by 2020


A defibrillator device depolarizes a critical part of a heart muscle thereby helping in restoration of normal heart rhythm. If SCA victims receive cardiopulmonary resuscitation (CPR) and defibrillation within 5 to 12 minutes of cardiac arrest, many lives can be saved. Growing incidences of cardiovascular disease and increasing healthcare infrastructure in the Middle East and Africa are the major factors expected to boost the growth in demand for defibrillators in the region. However, despite an excellent market opportunity in the Middle East and Africa, lack of awareness pertaining to operating of a defibrillator during emergency and unfavorable government intervention to install automated external defibrillators (AEDs) in public places are the key restraints for the growth of market in the Middle East and Africa. The Middle East and Africa defibrillators market was valued at USD 209.6 million in 2013 and is expected to reach an estimated value of USD 347.8 million by 2020, growing at a CAGR of 7.6%.
The Middle East and Africa defibrillators market has been segmented on the basis of product type, by end-users and by geography. On the basis of defibrillator type, the market is categorized into automated external defibrillators (AEDs) and advanced life support (ALS) defibrillators. Advanced life support defibrillators are used by medical and paramedical professionals, and emergency medical team. These defibrillators are also called as monitor/defibrillators since they possess an ability to monitor different kinds of bodily functions such as blood oxygen levels, pulse and heart rhythm. In 2013, the ALS defibrillators market accounted for the largest share by revenue in the market. The Middle East and Africa defibrillators market has also been segmented by end-user into hospitals, public access, emergency medical services and business workplaces. The defibrillators market in the region was dominated by hospitals as an end-user category accounting for more than 80% of the total market. Such high demand for defibrillators from hospitals is due to the continuous demand for ALS defibrillators as well as installation of AEDs at large hospitals.
The Middle East and Africa defibrillators market is also segmented by major countries in the region, namely, Saudi Arabia, United Arab Emirates, Jordan, Qatar, Algeria, Egypt, and South Africa. In 2013, Saudi Arabia and U.A.E. dominated the Middle East defibrillators market while South Africa led the Africa defibrillators market. The overall rise in the health care infrastructure in these countries along with the increasing awareness about the utility of defibrillators in cardiac arrest has driven growth in the demand for defibrillators. Saudi Arabia and Qatar are the fastest growing markets in the Middle East and Africa defibrillators market. The increasing awareness about utility of defibrillators in the Middle-East, especially in U.A.E and the support from government is contributing to growth of the market in this region.
The Middle East and Africa market is consolidated with 3-4 leading players in the market. Almost every leading company is situated outside the region and operates in the region, mostly through distribution arrangements. Most of the companies in the global defibrillators market are eager to leverage on the untapped market opportunity in the Middle East and Africa through forging distribution agreements in the region, setting up own distribution network or by establishing a local subsidiary in the region.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Cardiopulmonary Stress Testing Systems Market to Rise at a CAGR 8.20% by 2023


The dramatic change in lifestyles marred by poor dietary intake, lack of exercise, and stressful schedules have all worked towards making the global population susceptible to obesity and related disorders. A growing consequence of this is seen in the rising number of cardiac patients, who, in turn, have increased the uptake of cardiopulmonary stress testing systems. These systems are used for evaluating the condition of the patient’s heart. According to the World Health Organization (WHO), coronary artery diseases account for 64% of overall cardiovascular deaths across the globe, which has become the primary cursor for increasing sales of cardiopulmonary stress testing systems. In a bid to help patients take well-calculated preventive measures, healthcare centers are adopting various types of cardiopulmonary stress testing systems to provide holistic health checkups.
Transparency Market Research’s recently published report states that the opportunity in the global cardiopulmonary stress testing systems will be worth US$6.67 bn by 2023 as compared to US$3.30 bn in 2014. Between 2015 and 2023, the market is expected to rise at a CAGR of 8.20%. The global market will also receive a boost from growing healthcare infrastructure in the developing countries. The increasing disposable incomes, rising awareness amongst people about cardiovascular diseases and other related conditions, and the burgeoning health insurance industry are collectively expected to provide this market an impetus.
Obesity Continues to Fuel North America Market
The North America cardiopulmonary stress testing systems market is expected to expand at a CAGR of 7.3% between 2015 and 2023. The growth in this region will be attributable to the high adoption rate of cardiac monitoring equipment such as cardiopulmonary exercise testing (CPET) systems, pulse oximeters, stress ECG, SPECT, and stress blood pressure monitors. A high incidence of cardiac disorders in the region due to rising cases of obesity are the prime reason for the remarkable growth of this regional market.
The presence of leading equipment manufacturers in the North America cardiopulmonary stress testing systems market, high awareness amongst people, and enactment of laws such as Affordable Healthcare Act have further bolstered the demand for such equipment in the recent years. The market in North America has also benefited from supportive healthcare infrastructure and introduction of innovative products with ongoing research and development activities.
Asia Pacific is anticipated to be the next big regional market in the overall cardiopulmonary stress testing systems market. The improving purchasing power of consumers, a huge population base, and growing number of patients being diagnosed with cardiovascular diseases will keep this region at the forefront of the global market in the near future.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:

Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018

In the past few decades, the medical community all across the world has increasingly engaged in the use of apheresis. In therapeutic apheresis, a patient’s plasma or blood cellular parts are split and removed from the blood and replaced by substitute plasma or substitute blood fluids. The rationale behind apheresis is that the abnormal substances or cells in the patient’s blood are removed through apheresis, thereby leading to cure or control of the disease.
Therapeutic apheresis is not a new application, but its extent and scope has rapidly grown in the last two decades. At present, apheresis is primarily accepted as an acute therapeutic method in a variety of diseases, and millions of patients undergo the treatment every year. Today, apheresis is being evaluated as a treatment option for a wide range of chronic diseases such as rheumatoid arthritis, different forms of cancer, polyneuropathies, multiple sclerosis, and others.
The American Society for Apheresis published an edition of guidelines for the practice of therapeutic apheresis in 2010. All the guidelines mentioned by the Society are based on the review of scientific literature on apheresis. The clinical utility of any mentioned disease in the guidelines is denoted by a category (I – IV). In addition, the quality and the strength of the available clinical evidence of such disease is denoted by standard grade recommendations.
The major market drivers influencing the growth of apheresis equipments business are the rise in demand for plasma and plasma products, improvement in healthcare infrastructure in emerging economies and improvement in the status of reimbursement policies. However, factors such as lack of donor availability and histocompatibility issues, costly therapeutic methods, and lack of highly trained technicians might hamper the growth in demand for apheresis equipments.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
Posted by at No comments:
Subscribe to: Comments (Atom)